Results 181 to 190 of about 14,385 (213)

CD123

2016
openaire   +1 more source

CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping

Cytometry Part B - Clinical Cytometry, 2019
Anne E Bras, Vincent H J van der Velden
exaly  

A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells

International Journal of Pharmaceutics, 2017
Qiantao Wang, Shengjun Mao, Liu furong
exaly  

Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm

Expert Review of Clinical Pharmacology, 2019
Andrew A Lane, Naveen Pemmaraju, Minas P Economides   +2 more
exaly  

COMPOSITIONS AND METHODS FOR CD123 MODIFICATION

2021
LYDEARD JOHN, LUO CHONG, MISHRA BIBHU PRASAD, LIN MICHELLE   +3 more
openaire   +2 more sources

COMPOSITIONS AND METHODS FOR CD123 MODIFICATION

2022
LYDEARD JOHN, LUO CHONG, LIN MICHELLE, MISHRA BIBHU, LISLE JESSICA   +4 more
openaire   +1 more source

Antibody therapeutics that bind CD123

2016
ZHOU HEYUE, GRAY JOHN DIXON
openaire   +6 more sources

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Molecular Therapy, 2017
Luca Simonelli, Andrea Biondi, Luca Varani   +2 more
exaly  

CD123 ANTIBODIES AND CONJUGATES THEREOF

2016
SUTHERLAND MAY KUNG, WESTENDORF LORI, SUSSMAN DJANGO   +2 more
openaire   +3 more sources

ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY BIND TO CD3 AND/OR CD123

2023
JANA ALBRECHT, CEDRIC BARRIERE, CHIRSTIAN BIEL, JOCHEN BENINGA, CHANTAL CARREZ, STEPHANE GUERIF, KATJA KROLL, CHRISTIAN LANGE, CENDRINE LEMOINE, WULF-DIRK LEUSCHNER, ERCOLE RAO, MARION SCHNEIDER, MARIE-CECILE WETZEL, PETER WONEROW   +13 more
openaire   +1 more source